Thy One Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 5.00 M
- Company Age 5 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 7.50 M
About Thy One Life Sciences
Thy One Life Sciences Private Limited (TOLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 26 June 2019 (Five years and seven months 8 days old ). Its registered office is in Jalandhar, Punjab, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹7.50 M.
Vinay Soni, Neelam Kanwar, Khushivinder Kaur, and One other member serve as directors at the Company.
Company Details
-
Location
Jalandhar, Punjab, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24299PB2019PTC049672
-
Company No.
049672
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
26 Jun 2019
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Chandigarh
Industry
Who are the key members and board of directors at Thy One Life Sciences?
Board Members (4)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Vinay Soni | Additional Director | 05-Apr-2024 | Current |
Neelam Kanwar | Director | 26-Jun-2019 | Current |
Khushivinder Kaur | Director | 26-Jun-2019 | Current |
Surinder Kanwar | Director | 26-Jun-2019 | Current |
Financial Performance of Thy One Life Sciences.
Enhance accessibility to Thy One Life Sciences's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
|
||||||
Revenue from Operations |
|
||||||
Total Assets |
|
||||||
Profit or Loss |
|
||||||
Net Worth |
|
||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Thy One Life Sciences?
Unlock access to Thy One Life Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹7.50 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.75 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
24 Jun 2024 | Others | ₹7.50 M | Open |
How Many Employees Work at Thy One Life Sciences?
Thy One Life Sciences has a workforce of 40 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Thy One Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Thy One Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.